ArticleBMJ open2025

Risk of hepatitis B virus reactivation associated with interleukin inhibitor therapies: protocol for a systematic review and meta-analysis.

Marouf Mouhammad Alhalabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.